UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K
CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act 1934

Date of Report (date of earliest event reported): December 8, 2010


American Oriental Bioengineering, Inc.
(Exact name of registrant as specified in charter)

Nevada
(State or other jurisdiction of incorporation)

001-32569
84-0605867
(Commission File Number)
IRS Employer Identification No.)

1 Liangshuihe First Ave, Beijing E-Town Economic and Technology Development Area, E-Town,
Beijing, 100176, People’s Republic of China

 (Address of principal executive offices and zip code)
 

 
86-10-5982-2039

(Registrant’s telephone number including area code)



 (Registrant’s former name or former address, if changed since last report)

 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of registrant under any of the following provisions:
 
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 



 
 

 

Item 5.07  Submission of Matters to a Vote of Security Holders.
 
 
On December 8, 2010, American Oriental Bioengineering, Inc. (the “Company”) held its annual meeting of stockholders (“Annual Meeting”) to vote on the following matters:
 
1.  Election of Directors
 
All of the following nine nominees were elected to the Company’s Board of Directors, in accordance with the voting results listed below, to serve for a term of one year, until the next Annual Meeting and until their successors have been duly elected and have qualified.
 
Directors
For
Votes
Against
Broker Non-
Votes
Tony Liu
40,258,046
0
30,954,157
Jun Min
39,316,176
0
30,954,157
Yanchun “Lily” Li
39,309,218
0
30,954,157
Binsheng Li
40,346,475
0
30,954,157
Cosimo J. Patti
40,374,513
0
30,954,157
Xianmin Wang
39,079,691
0
30,954,157
Eileen Bridget Brody
40,377,449
0
30,954,157
Lawrence S. Wizel
40,371,436
0
30,954,157
Baiqing Zhang
40,354,764
0
30,954,157

 
2.  Ratification of the Company’s Independent Auditors
 
The stockholders of the Company ratified the appointment of Ernst & Young Hua Ming as independent auditors to audit the financial statements of the Company for the fiscal year ending December 31, 2010, in accordance with the voting results listed below.
 
For
Votes
Against
Abstain
81,258,030
685,639
171,188
 
 

 
 
2

 

 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 

 
AMERICAN ORIENTAL BIOENGINEERING, INC.
 
Dated: December 12, 2010
By:  /s/ Tony Liu                  
 
Name: Tony Liu
 
Title: Chairman and Chief Executive Officer
 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3